|
|
Blood, 15 January 2004, Vol. 103, No. 2, pp. 664-672.
Prepublished online as a Blood First Edition Paper on September 22, 2003; DOI 10.1182/blood-2003-05-1716.
Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46
Tal I. Arnon,
Hagit Achdout,
Niva Lieberman,
Roi Gazit,
Tsufit Gonen-Gross,
Gil Katz,
Ahuva Bar-Ilan,
Noga Bloushtain,
Marianna Lev,
Aviva Joseph,
Eli Kedar,
Angel Porgador, and
Ofer Mandelboim
From The Lautenberg Center for General and Tumor Immunology, The Hebrew University Hadassah Medical School, Jerusalem, Israel; the Department of Microbiology and Immunology, Faculty of Health Sciences, and the Cancer Research Center, Ben-Gurion University of the Negev, Beer Sheva, Israel.
The destruction of viral-infected and tumor cells is mediated in part via the lysis receptor of natural killer (NK) cells, NKp46. The nature, however, of its lysis ligands expressed on target cells is poorly defined. Recently, we have identified a novel functional interaction between the lysis receptors NKp46 and NKp44 and the hemagglutinin of influenza and hemgglutininneuroaminidase of Sendai viruses. This recognition depends on the sialylation of NKp46 and NKp44 receptors. In this study, we expand the significance of these observations by demonstrating a conserved pattern of NKp46 and NKp44 recognition by various hemagglutinins derived from different viral strains. We further establish that this recognition is direct and mainly mediated via 2,6-linked sialic acid carried by NKp46. In addition, we demonstrate that the ability of NKp46 to recognize target cells is confined to the membrane proximal domain, and largely relies on the highly conserved sugar-carrying residue, Thr 225. This residue plays a critical dual role in NKp46 interactions with both viral hemagglutinins and the unknown tumor ligands via different mechanisms. These results may explain the ability of NK cells to kill such a broad spectrum of viral-infected and tumor cells.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Komaru, Y. Ueda, A. Furuya, S. Tanaka, K. Yoshida, T. Kato, H. Kinoh, Y. Harada, H. Suzuki, M. Inoue, et al.
Sustained and NK/CD4+ T Cell-Dependent Efficient Prevention of Lung Metastasis Induced by Dendritic Cells Harboring Recombinant Sendai Virus
J. Immunol.,
October 1, 2009;
183(7):
4211 - 4219.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Mao, W. Tu, G. Qin, H. K. W. Law, S. F. Sia, P.-L. Chan, Y. Liu, K.-T. Lam, J. Zheng, M. Peiris, et al.
Influenza Virus Directly Infects Human Natural Killer Cells and Induces Cell Apoptosis
J. Virol.,
September 15, 2009;
83(18):
9215 - 9222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Hershkovitz, B. Rosental, L. A. Rosenberg, M. E. Navarro-Sanchez, S. Jivov, A. Zilka, O. Gershoni-Yahalom, E. Brient-Litzler, H. Bedouelle, J. W. Ho, et al.
NKp44 Receptor Mediates Interaction of the Envelope Glycoproteins from the West Nile and Dengue Viruses with NK Cells
J. Immunol.,
August 15, 2009;
183(4):
2610 - 2621.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Heltzer, S. E. Coffin, K. Maurer, A. Bagashev, Z. Zhang, J. S. Orange, and K. E. Sullivan
Immune dysregulation in severe influenza
J. Leukoc. Biol.,
June 1, 2009;
85(6):
1036 - 1043.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Wang, A. Ottosson, C. Ji, X. Feng, M. Nordenskjold, J.-I. Henter, B. Fadeel, and C. Zheng
Proteasome inhibition induces apoptosis in primary human natural killer cells and suppresses NKp46-mediated cytotoxicity
Haematologica,
April 1, 2009;
94(4):
470 - 478.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. G. Halfteck, M. Elboim, C. Gur, H. Achdout, H. Ghadially, and O. Mandelboim
Enhanced In Vivo Growth of Lymphoma Tumors in the Absence of the NK-Activating Receptor NKp46/NCR1
J. Immunol.,
February 15, 2009;
182(4):
2221 - 2230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Achdout, I. Manaster, and O. Mandelboim
Influenza Virus Infection Augments NK Cell Inhibition through Reorganization of Major Histocompatibility Complex Class I Proteins
J. Virol.,
August 15, 2008;
82(16):
8030 - 8037.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Manaster, S. Mizrahi, D. Goldman-Wohl, H. Y. Sela, N. Stern-Ginossar, D. Lankry, R. Gruda, A. Hurwitz, Y. Bdolah, R. Haimov-Kochman, et al.
Endometrial NK Cells Are Special Immature Cells That Await Pregnancy
J. Immunol.,
August 1, 2008;
181(3):
1869 - 1876.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Iannello, O. Debbeche, S. Samarani, and A. Ahmad
Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS
J. Leukoc. Biol.,
July 1, 2008;
84(1):
1 - 26.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Ho, O. Hershkovitz, M. Peiris, A. Zilka, A. Bar-Ilan, B. Nal, K. Chu, M. Kudelko, Y. W. Kam, H. Achdout, et al.
H5-Type Influenza Virus Hemagglutinin Is Functionally Recognized by the Natural Killer-Activating Receptor NKp44
J. Virol.,
February 15, 2008;
82(4):
2028 - 2032.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Hershkovitz, M. Jarahian, A. Zilka, A. Bar-Ilan, G. Landau, S. Jivov, Y. Tekoah, R. Glicklis, J. T. Gallagher, S. C. Hoffmann, et al.
Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: a lesson for the use of recombinant immunoreceptors as an immunological tool
Glycobiology,
January 1, 2008;
18(1):
28 - 41.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Owen, E. Yamada, C. I. Thompson, L. J. Phillipson, C. Thompson, E. Taylor, M. Zambon, H. M. I. Osborn, W. S. Barclay, and P. Borrow
Alterations in Receptor Binding Properties of Recent Human Influenza H3N2 Viruses Are Associated with Reduced Natural Killer Cell Lysis of Infected Cells
J. Virol.,
October 15, 2007;
81(20):
11170 - 11178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Roda-Navarro and H. T. Reyburn
Intercellular protein transfer at the NK cell immune synapse: mechanisms and physiological significance
FASEB J,
June 1, 2007;
21(8):
1636 - 1646.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Estefania, R. Flores, N. Gomez-Lozano, H. Aguilar, M. Lopez-Botet, and C. Vilches
Human KIR2DL5 Is an Inhibitory Receptor Expressed on the Surface of NK and T Lymphocyte Subsets
J. Immunol.,
April 1, 2007;
178(7):
4402 - 4410.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Draghi, A. Pashine, B. Sanjanwala, K. Gendzekhadze, C. Cantoni, D. Cosman, A. Moretta, N. M. Valiante, and P. Parham
NKp46 and NKG2D Recognition of Infected Dendritic Cells Is Necessary for NK Cell Activation in the Human Response to Influenza Infection
J. Immunol.,
March 1, 2007;
178(5):
2688 - 2698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Wendt, E. Wilk, S. Buyny, J. Buer, R. E. Schmidt, and R. Jacobs
Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells
J. Leukoc. Biol.,
December 1, 2006;
80(6):
1529 - 1541.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Betser-Cohen, G. Katz, T. Gonen-Gross, N. Stern, T. I. Arnon, H. Achdout, R. Gazit, and O. Mandelboim
Reduced KIR2DL1 Recognition of MHC Class I Molecules Presenting Phosphorylated Peptides.
J. Immunol.,
June 1, 2006;
176(11):
6762 - 6769.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Cebo, S. Da Rocha, S. Wittnebel, A. G. Turhan, J. Abdelali, S. Caillat-Zucman, J. H. Bourhis, S. Chouaib, and A. Caignard
The Decreased Susceptibility of Bcr/Abl Targets to NK Cell-Mediated Lysis in Response to Imatinib Mesylate Involves Modulation of NKG2D Ligands, GM1 Expression, and Synapse Formation
J. Immunol.,
January 15, 2006;
176(2):
864 - 872.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. T. Bryceson, M. E. March, H.-G. Ljunggren, and E. O. Long
Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion
Blood,
January 1, 2006;
107(1):
159 - 166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Munz, R. M. Steinman, and S.-i. Fujii
Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity
J. Exp. Med.,
July 18, 2005;
202(2):
203 - 207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. S. Warren, A. L. Jones, C. Freeman, J. Bettadapura, and C. R. Parish
Evidence That the Cellular Ligand for the Human NK Cell Activation Receptor NKp30 Is Not a Heparan Sulfate Glycosaminoglycan
J. Immunol.,
July 1, 2005;
175(1):
207 - 212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Azuz-Lieberman, G. Markel, S. Mizrahi, R. Gazit, J. Hanna, H. Achdout, R. Gruda, G. Katz, T. I. Arnon, S. Battat, et al.
The involvement of NK cells in ankylosing spondylitis
Int. Immunol.,
July 1, 2005;
17(7):
837 - 845.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Bloushtain, U. Qimron, A. Bar-Ilan, O. Hershkovitz, R. Gazit, E. Fima{dagger}, M. Korc, I. Vlodavsky, N. V. Bovin, and A. Porgador
Membrane-Associated Heparan Sulfate Proteoglycans Are Involved in the Recognition of Cellular Targets by NKp30 and NKp46
J. Immunol.,
August 15, 2004;
173(4):
2392 - 2401.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|